Andrei Coliţă
- Hematology top 10%
- Acute Myeloid Leukemia Research 13
- Hematopoietic Stem Cell Transplantation 5
-
- Chronic Lymphocytic Leukemia Research 9
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
-
- Lymphoma Diagnosis and Treatment 5
-
- T-cell and Retrovirus Studies 3
-
- Hematological disorders and diagnostics 4
-
- Acute Lymphoblastic Leukemia research 5
Andrei Coliţă
32 papers receiving 149 citations
Peers
Comparison fields: 5 of 37
- Hematology 90
- Genetics 54
- Pathology and Forensic Medicine 30
- Immunology 20
- Emergency Medicine 9
Countries citing papers authored by Andrei Coliţă
This map shows the geographic impact of Andrei Coliţă's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrei Coliţă with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrei Coliţă more than expected).
Fields of papers citing papers by Andrei Coliţă
This network shows the impact of papers produced by Andrei Coliţă. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrei Coliţă. The network helps show where Andrei Coliţă may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrei Coliţă, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 27 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 1 | |
| 7 | 2021 | 4 | |
| 8 | 2021 | 2 | |
| 9 | Comparison of peripheral blood stem cell mobilization with filgrastim versus pegfilgrastim in lymphoma patients - single center experience. | 2021 | 0 |
| 10 | 2020 | 3 | |
| 11 | 2020 | 14 | |
| 12 | 2019 | 15 | |
| 13 | 2018 | 2 | |
| 14 | The impact of additional cytogenetic abnormalities at diagnosis and during therapy with tyrosine kinase inhibitors in Chronic Myeloid Leukaemia. | 2016 | 13 |
| 15 | A trans-theoretical approach to alcohol abuse profile in the general population of an islamic country - Mashhad, Iran. | 2015 | 5 |
| 16 | 2013 | 4 | |
| 17 | 2012 | 2 | |
| 18 | Post-transplant lymphoproliferative disorders after solid organ transplantation in children. | 2012 | 1 |
| 19 | 2001 | 18 | |
| 20 | [Acute promyelocytic leukemia. A study of 119 cases and a review of the literature]. | 1988 | 1 |
About Andrei Coliţă
Andrei Coliţă is a scholar working on Hematology, Genetics and Emergency Medicine, having authored 38 papers that have together received 153 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (13 papers), Chronic Lymphocytic Leukemia Research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Acute Lymphoblastic Leukemia research (5 papers), Hematopoietic Stem Cell Transplantation (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Hematological disorders and diagnostics (4 papers) and T-cell and Retrovirus Studies (3 papers). The work is most often cited by research in Hematology (90 citations), Genetics (54 citations) and Pathology and Forensic Medicine (30 citations). Andrei Coliţă has collaborated with scholars based in Romania, France and Slovakia. Frequent co-authors include Daniel Coriu, Anca Coliţă, Alina Tănase, Youcef Chelghoum, Oana Stanca, C Charrin, D Fière, Ciprian Tomuleasa, Xavier Thomas and Horia Bumbea. Their work appears in journals such as Journal of Clinical Medicine, Frontiers in Oncology, Biomedicines, Annals of Oncology and Genes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.